These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 9445322)
21. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tilley BC; Lyden PD; Brott TG; Lu M; Levine SR; Welch KM Arch Neurol; 1997 Dec; 54(12):1466-74. PubMed ID: 9400355 [TBL] [Abstract][Full Text] [Related]
22. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460 [TBL] [Abstract][Full Text] [Related]
23. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. Katzan IL; Furlan AJ; Lloyd LE; Frank JI; Harper DL; Hinchey JA; Hammel JP; Qu A; Sila CA JAMA; 2000 Mar; 283(9):1151-8. PubMed ID: 10703777 [TBL] [Abstract][Full Text] [Related]
24. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. Patel SC; Levine SR; Tilley BC; Grotta JC; Lu M; Frankel M; Haley EC; Brott TG; Broderick JP; Horowitz S; Lyden PD; Lewandowski CA; Marler JR; Welch KM; JAMA; 2001 Dec; 286(22):2830-8. PubMed ID: 11735758 [TBL] [Abstract][Full Text] [Related]
28. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis? Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681 [TBL] [Abstract][Full Text] [Related]
29. [Treatment with intravenous rt-PA in a general hospital context: A review of the Saint-Jean Hospital experience from Perpignan, France]. Sablot D; Cassarini JF; Akouz A; Benejean JM; Leibinger F; Faillie X; Vidry E; Ayrignac X; Castro S; Sinaya L; Bertrand JL; Garcia Y; Arnoud B; Negre C Rev Neurol (Paris); 2006 Nov; 162(11):1109-17. PubMed ID: 17086147 [TBL] [Abstract][Full Text] [Related]
30. Ischemic stroke and excellent recovery after administration of intravenous tissue plasminogen activator. Jain SV; Morton LD Pediatr Neurol; 2008 Feb; 38(2):126-9. PubMed ID: 18206794 [TBL] [Abstract][Full Text] [Related]
32. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Haley EC; Levy DE; Brott TG; Sheppard GL; Wong MC; Kongable GL; Torner JC; Marler JR Stroke; 1992 May; 23(5):641-5. PubMed ID: 1579959 [TBL] [Abstract][Full Text] [Related]
33. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821 [TBL] [Abstract][Full Text] [Related]